{"id":111725,"date":"2026-07-16T09:24:54","date_gmt":"2026-07-16T12:24:54","guid":{"rendered":"https:\/\/med.estrategia.com\/portal\/?p=111725"},"modified":"2026-07-16T09:25:24","modified_gmt":"2026-07-16T12:25:24","slug":"cfm-regulamenta-uso-de-plasma-rico-em-plaquetas-prp-na-medicina","status":"publish","type":"post","link":"https:\/\/med.estrategia.com\/portal\/noticias\/cfm-regulamenta-uso-de-plasma-rico-em-plaquetas-prp-na-medicina\/","title":{"rendered":"CFM regulamenta uso de plasma rico em plaquetas (PRP) na medicina"},"content":{"rendered":"<p class=\"wp-block-paragraph\">O Conselho Federal de Medicina (CFM) publicou na quarta-feira, 15 de julho, a Resolu&ccedil;&atilde;o n&ordm; 2.464\/2026, que<strong> regulamenta o uso do plasma rico em plaquetas (PRP) <\/strong>como procedimento m&eacute;dico adjuvante no <strong>tratamento de condi&ccedil;&otilde;es osteomusculares espec&iacute;ficas<\/strong>. A norma entrou em vigor na data de sua publica&ccedil;&atilde;o no <em>Di&aacute;rio Oficial da Uni&atilde;o<\/em>.<p class=\"wp-block-paragraph\">A nova regulamenta&ccedil;&atilde;o <strong>revoga a Resolu&ccedil;&atilde;o CFM n&ordm; 2.128\/2015<\/strong>, que classificava o uso do PRP em doen&ccedil;as musculoesquel&eacute;ticas como experimental. Com a atualiza&ccedil;&atilde;o, o Conselho passa a permitir sua <strong>utiliza&ccedil;&atilde;o em indica&ccedil;&otilde;es espec&iacute;ficas<\/strong>, desde que sejam observados crit&eacute;rios t&eacute;cnicos, &eacute;ticos e sanit&aacute;rios previstos na norma.<\/p><div class=\"wp-block-buttons is-content-justification-center is-layout-flex wp-container-core-buttons-is-layout-fe48e5de wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button\"><a class=\"wp-block-button__link wp-element-button\" href=\"https:\/\/med.estrategia.com\/portal\/wp-content\/uploads\/2026\/07\/2464_2026.pdf\" target=\"_blank\">confira a resolu&ccedil;&atilde;o<\/a><\/div>\n<\/div><div id=\"ez-toc-container\" class=\"ez-toc-v2_0_86 counter-hierarchy ez-toc-counter ez-toc-transparent ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\"><p class=\"ez-toc-title\" style=\"cursor:inherit\">Navegue pelo conte\u00fado<\/p>\n<\/div><nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/med.estrategia.com\/portal\/noticias\/cfm-regulamenta-uso-de-plasma-rico-em-plaquetas-prp-na-medicina\/#Uso-passa-a-ser-permitido-em-quatro-condicoes\" >Uso passa a ser permitido em quatro condi&ccedil;&otilde;es<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/med.estrategia.com\/portal\/noticias\/cfm-regulamenta-uso-de-plasma-rico-em-plaquetas-prp-na-medicina\/#Resolucao-estabelece-criterios-para-aplicacao\" >Resolu&ccedil;&atilde;o estabelece crit&eacute;rios para aplica&ccedil;&atilde;o<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/med.estrategia.com\/portal\/noticias\/cfm-regulamenta-uso-de-plasma-rico-em-plaquetas-prp-na-medicina\/#Norma-tambem-define-vedacoes\" >Norma tamb&eacute;m define veda&ccedil;&otilde;es<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\" id=\"h-uso-passa-a-ser-permitido-em-quatro-condicoes\"><span class=\"ez-toc-section\" id=\"Uso-passa-a-ser-permitido-em-quatro-condicoes\"><\/span>Uso passa a ser permitido em quatro condi&ccedil;&otilde;es<span class=\"ez-toc-section-end\"><\/span><\/h2><p class=\"wp-block-paragraph\">A resolu&ccedil;&atilde;o autoriza o emprego do plasma rico em plaquetas como tratamento complementar para as seguintes condi&ccedil;&otilde;es osteomusculares:<\/p><ul class=\"wp-block-list\">\n<li><strong>osteoartrite de joelho<\/strong>;<\/li>\n\n\n\n<li><strong>discopatia lombar<\/strong>;<\/li>\n\n\n\n<li><strong>epicondilite lateral do cotovelo<\/strong>;<\/li>\n\n\n\n<li><strong>reparo meniscal<\/strong>.<\/li>\n<\/ul><p class=\"wp-block-paragraph\">Segundo o CFM, <strong>o PRP n&atilde;o substitui tratamentos cl&iacute;nicos, reabilitacionais, intervencionistas ou cir&uacute;rgicos quando estes forem indicados<\/strong>. A utiliza&ccedil;&atilde;o deve ser precedida de diagn&oacute;stico m&eacute;dico, avalia&ccedil;&atilde;o cl&iacute;nica individualizada, correla&ccedil;&atilde;o com exames complementares, exclus&atilde;o de contraindica&ccedil;&otilde;es e defini&ccedil;&atilde;o dos objetivos terap&ecirc;uticos para cada paciente.<\/p><h2 class=\"wp-block-heading\" id=\"h-resolucao-estabelece-criterios-para-aplicacao\"><span class=\"ez-toc-section\" id=\"Resolucao-estabelece-criterios-para-aplicacao\"><\/span>Resolu&ccedil;&atilde;o estabelece crit&eacute;rios para aplica&ccedil;&atilde;o<span class=\"ez-toc-section-end\"><\/span><\/h2><p class=\"wp-block-paragraph\">A norma define o plasma rico em plaquetas como um <strong>produto biol&oacute;gico aut&oacute;logo<\/strong>, <strong>obtido a partir do sangue perif&eacute;rico do pr&oacute;prio paciente mediante manipula&ccedil;&atilde;o m&iacute;nima<\/strong>. Tamb&eacute;m determina que a coleta, o processamento e a aplica&ccedil;&atilde;o observem as normas sanit&aacute;rias vigentes, sendo proibido o uso de material de origem alog&ecirc;nica, heter&oacute;loga ou sem rastreabilidade.<\/p><p class=\"wp-block-paragraph\">O processamento dever&aacute; seguir a <a href=\"https:\/\/www.gov.br\/anvisa\/pt-br\/centraisdeconteudo\/publicacoes\/sangue-tecidos-celulas-e-orgaos\/notas-tecnicas\/vigentes\/nota-tecnica-29-2024-gstco\/view\" target=\"_blank\">Nota T&eacute;cnica n&ordm; 29\/2024 da Ag&ecirc;ncia Nacional de Vigil&acirc;ncia Sanit&aacute;ria (Anvisa)<\/a>, preferencialmente por sistemas fechados. Nos procedimentos envolvendo a coluna vertebral, o PRP somente poder&aacute; ser utilizado em ambiente hospitalar ou hospital-dia, com orienta&ccedil;&atilde;o por imagem e realiza&ccedil;&atilde;o por m&eacute;dicos com Registro de Qualifica&ccedil;&atilde;o de Especialista (RQE) nas especialidades previstas pela resolu&ccedil;&atilde;o.<\/p><p class=\"wp-block-paragraph\">Al&eacute;m disso, a resolu&ccedil;&atilde;o estabelece que a <strong>indica&ccedil;&atilde;o, a aplica&ccedil;&atilde;o e o acompanhamento do PRP constituem atos m&eacute;dicos<\/strong> e <strong>classifica o procedimento como invasivo<\/strong>.<\/p><h2 class=\"wp-block-heading\" id=\"h-norma-tambem-define-vedacoes\"><span class=\"ez-toc-section\" id=\"Norma-tambem-define-vedacoes\"><\/span>Norma tamb&eacute;m define veda&ccedil;&otilde;es<span class=\"ez-toc-section-end\"><\/span><\/h2><p class=\"wp-block-paragraph\">Entre as <strong>proibi&ccedil;&otilde;es previstas pela resolu&ccedil;&atilde;o<\/strong> est&aacute; o <strong>uso do PRP como promessa de cura<\/strong>, <strong>garantia de regenera&ccedil;&atilde;o tecidual<\/strong> ou <strong>substitui&ccedil;&atilde;o de tratamentos cir&uacute;rgicos<\/strong> formalmente indicados. A norma tamb&eacute;m veda sua utiliza&ccedil;&atilde;o como substituto de terapias antimicrobianas, oncol&oacute;gicas, reumatol&oacute;gicas, neurol&oacute;gicas, ortop&eacute;dicas ou de urg&ecirc;ncia quando estas forem necess&aacute;rias.<\/p><p class=\"wp-block-paragraph\">O procedimento tamb&eacute;m <strong>n&atilde;o poder&aacute; ser realizado em pacientes com infec&ccedil;&atilde;o ativa no local da aplica&ccedil;&atilde;o, neoplasia ativa ou condi&ccedil;&otilde;es hematol&oacute;gicas incompat&iacute;veis<\/strong>, como plaquetopenia clinicamente relevante e coagulopatias n&atilde;o corrigidas. Antes da realiza&ccedil;&atilde;o do procedimento, o m&eacute;dico dever&aacute; <strong>obter consentimento livre e esclarecido do paciente<\/strong> e manter registro detalhado em prontu&aacute;rio sobre a indica&ccedil;&atilde;o, preparo, aplica&ccedil;&atilde;o e evolu&ccedil;&atilde;o cl&iacute;nica.<\/p><p class=\"wp-block-paragraph\">Se voc&ecirc; quer ficar por dentro de mais conte&uacute;dos relevantes sobre a &aacute;rea m&eacute;dica, continue acompanhando o material preparado pelo Portal de Not&iacute;cias do Estrat&eacute;gia MED. Aqui, voc&ecirc; encontrar&aacute; informa&ccedil;&otilde;es atualizadas sobre resid&ecirc;ncias, carreira m&eacute;dica e muito mais.<\/p><p class=\"wp-block-paragraph\"><a id=\"cta\" class=\"cta-imagem\" href=\"https:\/\/med.estrategia.com\/cursos\/simulados\/\" target=\"blank\">\n                <img decoding=\"async\" width=\"100%\" src=\"https:\/\/med.estrategia.com\/portal\/wp-content\/uploads\/2025\/08\/simulados_emed.jpg\" alt=\"\" title=\"simulados_emed\">\n        <\/a>\n<\/p><\/p>\n","protected":false},"excerpt":{"rendered":"Resolu\u00e7\u00e3o do CFM regulamenta o uso para quatro condi\u00e7\u00f5es osteomusculares e estabelece crit\u00e9rios para indica\u00e7\u00e3o e aplica\u00e7\u00e3o\n","protected":false},"author":39,"featured_media":111727,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"wl_entities_gutenberg":"","footnotes":""},"categories":[300],"tags":[],"wl_entity_type":[199],"class_list":["post-111725","post","type-post","status-publish","format-standard","has-post-thumbnail","category-noticias","wl_entity_type-article"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v26.6 (Yoast SEO v26.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>CFM regulamenta uso de plasma rico em plaquetas (PRP) na medicina<\/title>\n<meta name=\"description\" content=\"Resolu\u00e7\u00e3o do CFM regulamenta o uso de plasma rico em plaquetas para quatro condi\u00e7\u00f5es osteomusculares e estabelece crit\u00e9rios para indica\u00e7\u00e3o e aplica\u00e7\u00e3o\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/med.estrategia.com\/portal\/noticias\/cfm-regulamenta-uso-de-plasma-rico-em-plaquetas-prp-na-medicina\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CFM regulamenta uso de plasma rico em plaquetas (PRP) na medicina\" \/>\n<meta property=\"og:description\" content=\"Resolu\u00e7\u00e3o do CFM regulamenta o uso de plasma rico em plaquetas para quatro condi\u00e7\u00f5es osteomusculares e estabelece crit\u00e9rios para indica\u00e7\u00e3o e aplica\u00e7\u00e3o\" \/>\n<meta property=\"og:url\" content=\"https:\/\/med.estrategia.com\/portal\/noticias\/cfm-regulamenta-uso-de-plasma-rico-em-plaquetas-prp-na-medicina\/\" \/>\n<meta property=\"og:site_name\" content=\"Estrat\u00e9gia MED\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/estrategiamed1\" \/>\n<meta property=\"article:published_time\" content=\"2026-07-16T12:24:54+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-07-16T12:25:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/med.estrategia.com\/portal\/wp-content\/uploads\/2026\/07\/hands-holding-vial-prp-treatments-close-up.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1277\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Ana Carolina Damasceno\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@estrategiamed_\" \/>\n<meta name=\"twitter:site\" content=\"@estrategiamed_\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Ana Carolina Damasceno\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/med.estrategia.com\/portal\/noticias\/cfm-regulamenta-uso-de-plasma-rico-em-plaquetas-prp-na-medicina\/\",\"url\":\"https:\/\/med.estrategia.com\/portal\/noticias\/cfm-regulamenta-uso-de-plasma-rico-em-plaquetas-prp-na-medicina\/\",\"name\":\"CFM regulamenta uso de plasma rico em plaquetas (PRP) na medicina\",\"isPartOf\":{\"@id\":\"https:\/\/med.estrategia.com\/portal\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/med.estrategia.com\/portal\/noticias\/cfm-regulamenta-uso-de-plasma-rico-em-plaquetas-prp-na-medicina\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/med.estrategia.com\/portal\/noticias\/cfm-regulamenta-uso-de-plasma-rico-em-plaquetas-prp-na-medicina\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/med.estrategia.com\/portal\/wp-content\/uploads\/2026\/07\/hands-holding-vial-prp-treatments-close-up.jpg\",\"datePublished\":\"2026-07-16T12:24:54+00:00\",\"dateModified\":\"2026-07-16T12:25:24+00:00\",\"author\":{\"@id\":\"https:\/\/med.estrategia.com\/portal\/#\/schema\/person\/2f553adbb8e25fe39d145c5b2927f58c\"},\"description\":\"Resolu\u00e7\u00e3o do CFM regulamenta o uso de plasma rico em plaquetas para quatro condi\u00e7\u00f5es osteomusculares e estabelece crit\u00e9rios para indica\u00e7\u00e3o e aplica\u00e7\u00e3o\",\"breadcrumb\":{\"@id\":\"https:\/\/med.estrategia.com\/portal\/noticias\/cfm-regulamenta-uso-de-plasma-rico-em-plaquetas-prp-na-medicina\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/med.estrategia.com\/portal\/noticias\/cfm-regulamenta-uso-de-plasma-rico-em-plaquetas-prp-na-medicina\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/med.estrategia.com\/portal\/noticias\/cfm-regulamenta-uso-de-plasma-rico-em-plaquetas-prp-na-medicina\/#primaryimage\",\"url\":\"https:\/\/med.estrategia.com\/portal\/wp-content\/uploads\/2026\/07\/hands-holding-vial-prp-treatments-close-up.jpg\",\"contentUrl\":\"https:\/\/med.estrategia.com\/portal\/wp-content\/uploads\/2026\/07\/hands-holding-vial-prp-treatments-close-up.jpg\",\"width\":1920,\"height\":1277},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/med.estrategia.com\/portal\/noticias\/cfm-regulamenta-uso-de-plasma-rico-em-plaquetas-prp-na-medicina\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/med.estrategia.com\/portal\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Not\u00edcias\",\"item\":\"https:\/\/med.estrategia.com\/portal\/noticias\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"CFM regulamenta uso de plasma rico em plaquetas (PRP) na medicina\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/med.estrategia.com\/portal\/#website\",\"url\":\"https:\/\/med.estrategia.com\/portal\/\",\"name\":\"Estrat\u00e9gia MED\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/med.estrategia.com\/portal\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/med.estrategia.com\/portal\/#\/schema\/person\/2f553adbb8e25fe39d145c5b2927f58c\",\"name\":\"Ana Carolina Damasceno\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/med.estrategia.com\/portal\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/med.estrategia.com\/portal\/wp-content\/uploads\/2026\/07\/Sem-titulo-150x150.png\",\"contentUrl\":\"https:\/\/med.estrategia.com\/portal\/wp-content\/uploads\/2026\/07\/Sem-titulo-150x150.png\",\"caption\":\"Ana Carolina Damasceno\"},\"description\":\"Coordenadora de Jornalismo EMED. Comunicadora por natureza e forma\u00e7\u00e3o, que ama e perde a no\u00e7\u00e3o do tempo com m\u00fasica e s\u00e9rie.\",\"url\":\"https:\/\/med.estrategia.com\/portal\/author\/ana-carolina-damasceno\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"CFM regulamenta uso de plasma rico em plaquetas (PRP) na medicina","description":"Resolu\u00e7\u00e3o do CFM regulamenta o uso de plasma rico em plaquetas para quatro condi\u00e7\u00f5es osteomusculares e estabelece crit\u00e9rios para indica\u00e7\u00e3o e aplica\u00e7\u00e3o","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/med.estrategia.com\/portal\/noticias\/cfm-regulamenta-uso-de-plasma-rico-em-plaquetas-prp-na-medicina\/","og_locale":"pt_BR","og_type":"article","og_title":"CFM regulamenta uso de plasma rico em plaquetas (PRP) na medicina","og_description":"Resolu\u00e7\u00e3o do CFM regulamenta o uso de plasma rico em plaquetas para quatro condi\u00e7\u00f5es osteomusculares e estabelece crit\u00e9rios para indica\u00e7\u00e3o e aplica\u00e7\u00e3o","og_url":"https:\/\/med.estrategia.com\/portal\/noticias\/cfm-regulamenta-uso-de-plasma-rico-em-plaquetas-prp-na-medicina\/","og_site_name":"Estrat\u00e9gia MED","article_publisher":"https:\/\/www.facebook.com\/estrategiamed1","article_published_time":"2026-07-16T12:24:54+00:00","article_modified_time":"2026-07-16T12:25:24+00:00","og_image":[{"width":1920,"height":1277,"url":"https:\/\/med.estrategia.com\/portal\/wp-content\/uploads\/2026\/07\/hands-holding-vial-prp-treatments-close-up.jpg","type":"image\/jpeg"}],"author":"Ana Carolina Damasceno","twitter_card":"summary_large_image","twitter_creator":"@estrategiamed_","twitter_site":"@estrategiamed_","twitter_misc":{"Escrito por":"Ana Carolina Damasceno","Est. tempo de leitura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/med.estrategia.com\/portal\/noticias\/cfm-regulamenta-uso-de-plasma-rico-em-plaquetas-prp-na-medicina\/","url":"https:\/\/med.estrategia.com\/portal\/noticias\/cfm-regulamenta-uso-de-plasma-rico-em-plaquetas-prp-na-medicina\/","name":"CFM regulamenta uso de plasma rico em plaquetas (PRP) na medicina","isPartOf":{"@id":"https:\/\/med.estrategia.com\/portal\/#website"},"primaryImageOfPage":{"@id":"https:\/\/med.estrategia.com\/portal\/noticias\/cfm-regulamenta-uso-de-plasma-rico-em-plaquetas-prp-na-medicina\/#primaryimage"},"image":{"@id":"https:\/\/med.estrategia.com\/portal\/noticias\/cfm-regulamenta-uso-de-plasma-rico-em-plaquetas-prp-na-medicina\/#primaryimage"},"thumbnailUrl":"https:\/\/med.estrategia.com\/portal\/wp-content\/uploads\/2026\/07\/hands-holding-vial-prp-treatments-close-up.jpg","datePublished":"2026-07-16T12:24:54+00:00","dateModified":"2026-07-16T12:25:24+00:00","author":{"@id":"https:\/\/med.estrategia.com\/portal\/#\/schema\/person\/2f553adbb8e25fe39d145c5b2927f58c"},"description":"Resolu\u00e7\u00e3o do CFM regulamenta o uso de plasma rico em plaquetas para quatro condi\u00e7\u00f5es osteomusculares e estabelece crit\u00e9rios para indica\u00e7\u00e3o e aplica\u00e7\u00e3o","breadcrumb":{"@id":"https:\/\/med.estrategia.com\/portal\/noticias\/cfm-regulamenta-uso-de-plasma-rico-em-plaquetas-prp-na-medicina\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/med.estrategia.com\/portal\/noticias\/cfm-regulamenta-uso-de-plasma-rico-em-plaquetas-prp-na-medicina\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/med.estrategia.com\/portal\/noticias\/cfm-regulamenta-uso-de-plasma-rico-em-plaquetas-prp-na-medicina\/#primaryimage","url":"https:\/\/med.estrategia.com\/portal\/wp-content\/uploads\/2026\/07\/hands-holding-vial-prp-treatments-close-up.jpg","contentUrl":"https:\/\/med.estrategia.com\/portal\/wp-content\/uploads\/2026\/07\/hands-holding-vial-prp-treatments-close-up.jpg","width":1920,"height":1277},{"@type":"BreadcrumbList","@id":"https:\/\/med.estrategia.com\/portal\/noticias\/cfm-regulamenta-uso-de-plasma-rico-em-plaquetas-prp-na-medicina\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/med.estrategia.com\/portal\/"},{"@type":"ListItem","position":2,"name":"Not\u00edcias","item":"https:\/\/med.estrategia.com\/portal\/noticias\/"},{"@type":"ListItem","position":3,"name":"CFM regulamenta uso de plasma rico em plaquetas (PRP) na medicina"}]},{"@type":"WebSite","@id":"https:\/\/med.estrategia.com\/portal\/#website","url":"https:\/\/med.estrategia.com\/portal\/","name":"Estrat\u00e9gia MED","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/med.estrategia.com\/portal\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Person","@id":"https:\/\/med.estrategia.com\/portal\/#\/schema\/person\/2f553adbb8e25fe39d145c5b2927f58c","name":"Ana Carolina Damasceno","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/med.estrategia.com\/portal\/#\/schema\/person\/image\/","url":"https:\/\/med.estrategia.com\/portal\/wp-content\/uploads\/2026\/07\/Sem-titulo-150x150.png","contentUrl":"https:\/\/med.estrategia.com\/portal\/wp-content\/uploads\/2026\/07\/Sem-titulo-150x150.png","caption":"Ana Carolina Damasceno"},"description":"Coordenadora de Jornalismo EMED. Comunicadora por natureza e forma\u00e7\u00e3o, que ama e perde a no\u00e7\u00e3o do tempo com m\u00fasica e s\u00e9rie.","url":"https:\/\/med.estrategia.com\/portal\/author\/ana-carolina-damasceno\/"}]}},"_wl_alt_label":[],"wl:entity_url":"\/post\/cfm-regulamenta-uso-de-plasma-rico-em-plaquetas-prp-na-medicina-111725","_links":{"self":[{"href":"https:\/\/med.estrategia.com\/portal\/wp-json\/wp\/v2\/posts\/111725","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/med.estrategia.com\/portal\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/med.estrategia.com\/portal\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/med.estrategia.com\/portal\/wp-json\/wp\/v2\/users\/39"}],"replies":[{"embeddable":true,"href":"https:\/\/med.estrategia.com\/portal\/wp-json\/wp\/v2\/comments?post=111725"}],"version-history":[{"count":3,"href":"https:\/\/med.estrategia.com\/portal\/wp-json\/wp\/v2\/posts\/111725\/revisions"}],"predecessor-version":[{"id":111730,"href":"https:\/\/med.estrategia.com\/portal\/wp-json\/wp\/v2\/posts\/111725\/revisions\/111730"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/med.estrategia.com\/portal\/wp-json\/wp\/v2\/media\/111727"}],"wp:attachment":[{"href":"https:\/\/med.estrategia.com\/portal\/wp-json\/wp\/v2\/media?parent=111725"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/med.estrategia.com\/portal\/wp-json\/wp\/v2\/categories?post=111725"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/med.estrategia.com\/portal\/wp-json\/wp\/v2\/tags?post=111725"},{"taxonomy":"wl_entity_type","embeddable":true,"href":"https:\/\/med.estrategia.com\/portal\/wp-json\/wp\/v2\/wl_entity_type?post=111725"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}